Home » Topics » Regulatory

Regulatory
RSS

Invega Sustenna approved for acute and maintenance schizophrenia treatment

Aug. 5, 2009

FDA approves AstraZeneca and Bristol-Myers' Onglyza for type 2 diabetes

Aug. 4, 2009

Wyeth's Prevenar 13 pneumococcal vaccine approved in Chile

July 16, 2009

FDA granted marketing approval for AMAG's Feraheme in chronic kidney disease

July 1, 2009

FDA approves Allergan's Ozurdex for macular edema following retinal vein occlusion

June 22, 2009

FDA approves Novartis' monoclonal antibody Ilaris for children and adults with CAPS

June 18, 2009

FDA approves Besivance for bacterial conjunctivitis

June 2, 2009

European Commission grants marketing authorization to HRA Pharma's ellaOne

May 27, 2009

FDA approves Adcirca tablets for pulmonary arterial hypertension

May 27, 2009

FDA approves Otsuka's Samsca for hypervolemic and euvolemic hyponatremia

May 22, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 12, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
Research grants support early clinical trials of ALS treatments
BioWorld Science
The ALS Association has announced the recipients of its 2025 Hoffman ALS Clinical Trial Awards. These research grants, worth up to $1 million each, support...